Core Laboratories N.V. (CLB)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 878.69M |
| Enterprise value | 1.10B |
| Trailing P/E | 36.92 |
| Forward P/E | 22.17 |
| PEG ratio (5-yr expected) | 1.54 |
| Price/sales (ttm) | 1.76 |
| Price/book (mrq) | 4.50 |
| Enterprise value/revenue | 2.18 |
| Enterprise value/EBITDA | 16.88 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.41 |
| 52-week change 3 | -20.62% |
| S&P500 52-week change 3 | 29.31% |
| 52-week high 3 | 27.95 |
| 52-week low 3 | 13.82 |
| 50-day moving average 3 | 16.97 |
| 200-day moving average 3 | 19.11 |
Share statistics
| Avg vol (3-month) 3 | 373.83k |
| Avg vol (10-day) 3 | 370.28k |
| Shares outstanding 5 | 46.66M |
| Implied shares outstanding 6 | 46.91M |
| Float 8 | 46.48M |
| % held by insiders 1 | 0.85% |
| % held by institutions 1 | 105.64% |
| Shares short (30 Apr 2024) 4 | 5.97M |
| Short ratio (30 Apr 2024) 4 | 16.6 |
| Short % of float (30 Apr 2024) 4 | N/A |
| Short % of shares outstanding (30 Apr 2024) 4 | 12.80% |
| Shares short (prior month 28 Mar 2024) 4 | 6.59M |
Dividends & splits
| Forward annual dividend rate 4 | 0.04 |
| Forward annual dividend yield 4 | 0.21% |
| Trailing annual dividend rate 3 | 0.04 |
| Trailing annual dividend yield 3 | 0.22% |
| 5-year average dividend yield 4 | 1.96 |
| Payout ratio 4 | 7.84% |
| Dividend date 3 | 28 May 2024 |
| Ex-dividend date 4 | 03 May 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 09 Jul 2010 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 7.34% |
| Operating margin (ttm) | 7.64% |
Management effectiveness
| Return on assets (ttm) | 6.23% |
| Return on equity (ttm) | 17.40% |
Income statement
| Revenue (ttm) | 511.07M |
| Revenue per share (ttm) | 10.94 |
| Quarterly revenue growth (yoy) | 1.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 74.51M |
| Net income avi to common (ttm) | 37.52M |
| Diluted EPS (ttm) | 0.51 |
| Quarterly earnings growth (yoy) | 35.70% |
Balance sheet
| Total cash (mrq) | 14.91M |
| Total cash per share (mrq) | 0.32 |
| Total debt (mrq) | 212.28M |
| Total debt/equity (mrq) | 89.41% |
| Current ratio (mrq) | 2.68 |
| Book value per share (mrq) | 4.95 |
Cash flow statement
| Operating cash flow (ttm) | 33.49M |
| Levered free cash flow (ttm) | 30.03M |
© 2024 Yahoo. All rights reserved.